Metabolic Optimization Blueprint, LLC.

The Metabolic Optimization Blueprint (MOB) is pivoting its proprietary, historical data ecosystem into a validated, pharmaceutical-grade digital health asset. Managed by a lean, executive team combining visionary operations with elite Big Pharma clinical expertise, the venture is institutionalizing the world’s largest private metabolic database. 

The Solution & Proprietary Data Moat MOB does not compete with GLP-1 medications; it acts as their mandatory clinical companion. Driven by a customized, Basal Metabolic Rate (BMR) equation, the protocol forces targeted fat oxidation while preserving lean muscle. • The Moat: MOB owns an unassailable, real-world evidence (RWE) database of 41,400+ high-fidelity, longitudinal body composition scans tracking 1,600+ individuals weekly over 15 years. Already in conversations with Eli Lilly largest GLP-1 pharmaceutical Company. They are interested in the data to solve their muscle loss issues with GLP-1's.